Roche John C 4

What Happened
John C. Roche, President, Chief Executive Officer and a director of Hanover Insurance Group, was granted a total of 76,254 restricted stock units (RSUs/PBRSUs) on Feb 24, 2026. The filing shows four awards: 13,254; 8,540; 9,435; and 45,025 shares, reported as acquisitions at $0.00 (awards, not open‑market purchases), so no cash changed hands. One of the line items (45,025) is noted as a derivative award (reflecting performance/adjustments).

Key Details

• Transaction date: February 24, 2026; Form 4 filed Feb 26, 2026 (timely filing).
• Awards: 13,254 RSUs; 8,540 RSUs; 9,435 RSUs; 45,025 RSUs (total 76,254). Reported acquisition price: $0.00 (these are grants/awards).
• Vesting/conditions: Some awards are performance-based restricted stock units (PBRSUs) and remain subject to time-based vesting; vesting events and certification details are in footnotes (see below).
• Spouse holdings: Filing notes 14,454 shares held by the reporting person’s spouse are not included in these amounts.
• Filing timeliness: Not indicated as late; filing was submitted two days after the reported transactions (within standard Form 4 timing).

Context

• Performance certification: Per footnotes, PBRSUs granted on Feb 27, 2023 had their performance certifications on Feb 24, 2026 — one award certified at 150% of target (adjusted for dividend equivalents) and another at 100% of target. Both remain subject to the time-based vesting condition and are scheduled to vest on Feb 27, 2026.
• What this means for investors: These are company awards (not purchases or sales) and typically reflect compensation/long‑term incentive program outcomes rather than immediate insider buying or selling. Vesting (and subsequent tax events) will determine when the shares become owned and potentially tradable.